Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACAD | AMGN | GILD | VRTX | BIIB |
| Company | Acadia Pharmaceutica | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 16.29 | 333.93 | 83.37 | 483.78 | 198.13 |
| High | 16.73 | 339.00 | 84.52 | 483.78 | 199.78 |
| Low | 16.08 | 331.00 | 82.76 | 476.06 | 196.81 |
| Last | 16.43 | 333.72 | 84.03 | 476.99 | 197.87 |
| Change | +0.17 | +0.92 | +0.98 | -4.27 | -0.34 |
| % Change | +1.05% | +0.28% | +1.18% | -0.89% | -0.17% |
| Volume | 556,600 | 763,874 | 6,077,014 | 444,016 | 360,807 |
| 20-Day Average Volume | 1,162,405 | 1,703,773 | 6,258,449 | 957,816 | 785,530 |
| Previous Close | 16.26 | 332.80 | 83.05 | 481.26 | 198.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 16.10 | 329.42 | 79.66 | 480.48 | 201.94 |
| 20-Day Raw Stochastic | 76.73% | 87.95% | 95.64% | 44.43% | 47.85% |
| 20-Day Relative Strength | 52.59% | 57.88% | 72.86% | 49.40% | 42.25% |
| Weighted Alpha | -35.13 | +27.34 | +19.31 | +33.68 | -22.61 |
| Today's Opinion | 56% Sell | 96% Buy | 88% Buy | 40% Buy | 100% Sell |
| Previous Opinion | 72% Sell | 88% Buy | 88% Buy | 56% Buy | 100% Sell |
| Last Month's Opinion | 56% Sell | 72% Buy | 40% Buy | 88% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.39% since 09/11/24 | +1.95% since 09/11/24 | +4.34% since 09/11/24 | +0.74% since 09/11/24 | +0.25% since 09/11/24 |
| Low | 15.59 on 09/12/24 | 326.41 on 09/12/24 | 81.57 on 09/13/24 | 468.46 on 09/12/24 | 192.25 on 09/13/24 |
| High | 16.72 on 09/18/24 | 338.80 on 09/18/24 | 84.89 on 09/12/24 | 490.15 on 09/16/24 | 202.79 on 09/17/24 |
| 1-Month | |||||
| %Chg | +8.12% since 08/16/24 | +4.66% since 08/16/24 | +14.46% since 08/16/24 | +0.19% since 08/16/24 | -1.15% since 08/16/24 |
| Low | 15.28 on 08/19/24 | 319.00 on 09/06/24 | 73.27 on 08/19/24 | 460.69 on 09/11/24 | 192.25 on 09/13/24 |
| High | 17.03 on 09/03/24 | 338.80 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 | 207.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | +11.97% since 06/18/24 | +9.94% since 06/18/24 | +33.73% since 06/18/24 | +2.35% since 06/18/24 | -10.76% since 06/18/24 |
| Low | 14.73 on 06/20/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 | 192.25 on 09/13/24 |
| High | 19.44 on 07/31/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | -11.06% since 03/18/24 | +24.18% since 03/18/24 | +15.27% since 03/18/24 | +16.26% since 03/18/24 | -9.03% since 03/18/24 |
| Low | 14.55 on 06/10/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 19.44 on 07/31/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,686,494 | 178,525,568 | 103,468,096 | 124,190,592 | 28,858,782 |
| Shares Outstanding, K | 165,221 | 536,435 | 1,245,853 | 258,053 | 145,597 |
| Annual Sales | 726,440,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -61,290,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 241,960,000 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 | 2,464,900,000 |
| Last Quarter Net Income | 33,390,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 | 583,600,000 |
| 60-Month Beta | 0.40 | 0.61 | 0.18 | 0.40 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.20 on 08/06/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 | 5.28 on 08/01/24 |
| Latest Earnings Date | 11/07/24 | 10/29/24 | 11/05/24 | 11/04/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 89.67 | 18.02 | 17.69 | 0.00 | 12.27 |